Very bullish on 2025 despite demand concerns

Share

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins ‘Money Movers’ to discuss Jorgensen’s comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

03:42

Thu, Nov 7 202411:45 AM EST

Source link

Leave a Comment